8V8-32704-19939
4 vaccinations
11 coded responses
55 check-ins
10 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 060 / CT
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Breast discomfort, Breast swelling, Discomfort, Oedema peripheral — Feeling: Good · Site: SwellingFree text: Mild swelling left axilla and outer aspect left breast, soft, no redness, minimal discomfort (side of injection)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Breast swelling, Oedema peripheral — Feeling: GoodFree text: Previous left axillary and left breast puffiness decreasedMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Breast oedema, Oedema peripheral — Feeling: GoodFree text: Still with mild puffiness left axilla and outer aspect left breast. No pain noted.tMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Breast swelling, Oedema peripheral — Feeling: GoodFree text: Puffiness left axilla and left breast almost totally resolved. Area soft. No pain.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — day 7, dose 3MedDRA: Breast swelling, Oedema peripheral — Feeling: Good · HeadacheFree text: Prior puffiness left axilla and left breast has subsidedMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: Diverticulitis, Mobility decreased, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Diagnosed with diverticulitis 12/15/21-treated by PCP medically w/ antibiotics, bedrest, diet restrictions.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-29
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-03
- 2022-01-06
- 2022-03-30
-
2022-04-19
Dose 4 — Pfizer-BioNTech
- 2022-04-19
-
2022-04-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-21
Survey response — days 1–6 daily, dose 4MedDRA: Oedema peripheral, Skin swelling — Feeling: Good · Site: SwellingFree text: Puffiness left axilla (side of injection)-area soft and non-tenderMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Oedema peripheral — Feeling: GoodFree text: Left axillary puffiness is lessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Survey response — days 1–6 daily, dose 4MedDRA: Oedema peripheral — Feeling: GoodFree text: Left axillary puffiness mostly subsidedMedDRA releases: 2024-11 · check-in free text available
- 2022-04-24
- 2022-04-25
- 2022-04-26
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-05-24
- 2022-05-31
-
2022-07-19
Survey response — 3 months, dose 4MedDRA: Chills, Cough, Diarrhoea, Dizziness, Headache, Laryngitis, Lethargy, Malaise, Mobility decreased, Nausea, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test negative, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Became ill 6/27, sore throat, laryngitis. Progressed to fever, chills, cough, vomiting, diarrhea, severe lethargy,headache, nausea, dizziness, body aches 6/30 & 7/1. Unable to get out of bed for 2 days. 3 covid tests were negative. ? flu...MedDRA releases: 2024-11 · check-in free text available
-
2022-07-19
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-18
-
2023-04-19
Survey response — 12 months, dose 4MedDRA: COVID-19, Cough, Impaired work ability, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-04-19 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Mild swelling left axilla and outer aspect left breast, soft, no redness, minimal discomfort (side of injection)
Systemic reaction (other): Previous left axillary and left breast puffiness decreased
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Still with mild puffiness left axilla and outer aspect left breast. No pain noted.t
Systemic reaction (other): Puffiness left axilla and left breast almost totally resolved. Area soft. No pain.
Release 10 — day 7, dose 3
Systemic reaction (other): Prior puffiness left axilla and left breast has subsided
Release 10 — 3 months, dose 3
Symptoms: Diagnosed with diverticulitis 12/15/21-treated by PCP medically w/ antibiotics, bedrest, diet restrictions.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Puffiness left axilla (side of injection)-area soft and non-tender
Systemic reaction (other): Left axillary puffiness is less
Systemic reaction (other): Left axillary puffiness mostly subsided
Release 12 — 3 months, dose 4
Symptoms: Became ill 6/27, sore throat, laryngitis. Progressed to fever, chills, cough, vomiting, diarrhea, severe lethargy,headache, nausea, dizziness, body aches 6/30 & 7/1. Unable to get out of bed for 2 days. 3 covid tests were negative. ? flu...
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Diverticulitis | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Breast discomfort | · | · | ✓ |
| SRO | Breast oedema | · | · | ✓ |
| SRO | Breast swelling | · | · | ✓ |
| SRO | Discomfort | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Skin swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release